[Skip to Navigation]
The Cutting Edge: Challenges in Medical and Surgical Therapies
Aug 2011

Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab

Arch Dermatol. 2011;147(8):896-898. doi:10.1001/archdermatol.2011.185

A 58-year-old woman presented with a history of subacute cutaneous lupus erythematosus (SCLE) for the past 6 years, associated with photosensitivity, arthralgia, and fatigue. There was no evidence of systemic lupus erythematosus (SLE) or any history of exposure to drugs known to induce SCLE. Previous treatments included hydroxychloroquine sulfate, dapsone, prednisone, azathioprine, mycophenolate mofetil, topical corticosteroids, and tacrolimus 0.1% ointment, with limited benefit.